Pages that link to "Q71093043"

The following pages link to Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers (Q71093043):

Displaying 43 items.

• Relationship between therapeutic efficacy of arterial infusion chemotherapy and expression of P-glycoprotein and p53 protein in advanced hepatocellular carcinoma (Q33788566) (← links)
• Molecular pathogenesis of lung cancer (Q33793308) (← links)
• A novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer (Q34273617) (← links)
• Molecular abnormalities in lung carcinogenesis and their potential clinical implications (Q34447403) (← links)
• Molecular biology of lung cancer: clinical implications. (Q34569440) (← links)
• Recent advances in the molecular diagnosis of lung cancer (Q34936028) (← links)
• Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues (Q34997440) (← links)
• Clinical Implication of p53 Mutation in Lung Cancer (Q35127312) (← links)
• Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis (Q35587101) (← links)
• K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer (Q36420159) (← links)
• Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in pancreatic cancer (Q36423050) (← links)
• Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer. (Q36510150) (← links)
• p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival (Q36618938) (← links)
• Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers (Q36619686) (← links)
• Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy (Q36621064) (← links)
• Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. (Q37081762) (← links)
• Role of DMP1 and its future in lung cancer diagnostics (Q37111920) (← links)
• Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells (Q41439912) (← links)
• Prognostic markers in resectable non-small cell lung cancer (Q41519933) (← links)
• Topographical distributions of allelic loss in individual non-small-cell lung cancers (Q41839087) (← links)
• p53 and Bcl-2 expression in pneumoconiosis-related pre-cancerous lesions and lung cancers: Frequent and preferential p53 expression in pneumoconiotic bronchiolar dysplasias (Q42450834) (← links)
• Screening thep53 status of human cell lines using a yeast functional assay (Q42815910) (← links)
• p53 and angiogenesis in non-small-cell lung cancer (Q42858490) (← links)
• Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner (Q45872876) (← links)
• Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung (Q47418103) (← links)
• Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer (Q47951269) (← links)
• Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma (Q48657987) (← links)
• Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cells. (Q53363014) (← links)
• Progress in understanding the molecular pathogenesis of human lung cancer. (Q53431081) (← links)
• Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer. (Q54113153) (← links)
• A Study of Smoking, p53 Tumor Suppressor Gene Alterations and Non-Small Cell Lung Cancer (Q57272680) (← links)
• Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer (Q58454740) (← links)
• Prognostic impact of telomerase activity in non-small cell lung cancers (Q73181191) (← links)
• Clinical importance of correlations between p53 immunoreactivity and clinicopathological parameters in lung carcinoma (Q73295685) (← links)
• Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients (Q73446663) (← links)
• p53-regulated GML gene expression in non-small cell lung cancer. a promising relationship to cisplatin chemosensitivity (Q73549433) (← links)
• Association between p53 Mutation and Clinicopathological Features of Non-small Cell Lung Cancer (Q73901343) (← links)
• Molecular biological markers and micrometastasis in resected non-small-cell lung cancer. Prognostic implications (Q74569409) (← links)
• Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma (Q74585786) (← links)
• Gene therapy for lung cancer (Q74822016) (← links)
• Prognostic significance of thrombomodulin expression and vascular invasion in stage I squamous cell carcinoma of the lung (Q77197687) (← links)
• Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival (Q77376768) (← links)
• Clinical implications of molecular abnormalities in lung cancer (Q77711290) (← links)